The pathology of lung cancer-Changing concepts and newer diagnostic techniques

Seminars in Oncology

Volumn 15, Issue 3, 1988, Pages 215-225

  Gazdar, Adi F ^a   Linnoila, R Ilona ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTOCHEMISTRY; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; METHODOLOGY; REVIEW;

ADENOCARCINOMA; ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; CARCINOMA, ADENOID CYSTIC; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; EPITHELIUM; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; PRECANCEROUS CONDITIONS;

EID: 0023909902     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. The pathology of non-small cell carcinoma of the lung
2. Pathology of small cell carcinoma of the lung and its subtypes. A clinico-pathologic correlation
3. The World Health Organization histological typing of lung tumors
4. Current status of therapy for small cell carcinoma of the lung
5. Frequency of residual and metastatic tumor in patients undergoing curative surgical resection for lung cancer
6. The biology of endocrine lung tumors
7. Advances in the biology of non-small cell lung cancer
8. Cancer of the lung
9. The changing histopathology of lung cancer
10. Secular trends in histologic types of lung cancer
11. Development of carcinoma of the lung as reflected in exfoliated cells
12. Relationship of morphology to clinical presentation in ten cases of early squamous carcinoma of the lung
13. Intermediate filament and cross-linked envelope expression in human tumor cell lines
14. Biologic markers for squamous differentiation in human lung cancer cell lines
15. Human squamous cell lung cancers express increased epidermal growth factor receptors
16. Expression of epidermal growth factor receptor in human lung tumours
17. Immunohistochemical identification of epithelium-derived human tumors with antibodies to desmosomal plaque proteins
18. A parathyroid hormone related protein implicated in malignant hypercalcemia: cloning and expression
19. Ion transport by rabbit nonciliated bronchiolar epithelial cell (Clara cells) in culture
20. Carcinomas of the peripheral airways
21. Ultrastructural and immunohistochemical studies of bronchioloalveolar carcinoma
22. The pathobiologic features of carcinomas of Type II pneumocytes. An immunocytologic study
23. Evidence for the Clara cell as a site of cytochrome P450-dependent mixed-function oxidase activity in the lung
24. The fine structure of large cell undifferentiated carcinoma of the lung. Evidence for its relation to squamous cell carcinomas and adenocarcinomas
25. Atypical endocrine tumors of the lung
26. The nature of the ‘oat celled sarcoma’ of the mediastinum
27. Oat cell carcinoma of the bronchus
28. The pathology of endocrine tumors of the lung
29. Classification of lung cancer histology
30. Ultrastructure of lung neoplasms
31. Expression of peptide and other markers in lung cancer cell lines
32. Small cell lung cancer, endocrine cells of the fetal bronchus, and other neuroendocrine cells express Leu-7 antigenic determinant present on natural killer cells
33. Natural killer cell associated antigen NKH-1 is a marker for neuroendocrine tumors of the lung
34. Amphicrine cells, dysplasias and neoplasias
35. Preliminary report of a prospective trial of neuroendocrine marker analysis and in vitro drug sensitivity testing in patients with non-small cell lung cancer
36. Immunohistochemical techniques and their applications in the histopathology of the respiratory system
37. Keratin proteins and carcinoembryonic antigen in lung carcinoma. An immunoperoxidase study of fifty-four cases with ultrastructural correlations
38. Localization of CEA, B-HCG, SPI and keratin in the tissues of lung carcinomas. An immunohistochemical study
39. Use of antibodies to carcinoembryonic antigen and human milk fat globule to distinguish carcinoma, mesothelioma, and reactive mesothelium
40. Comparison of tumor markers in malignant mesothelioma and pulmonary adenocarcinoma
41. The distinction of adenocarcinoma from malignant mesothelioma in cell blocks and effusions: The role of routine mucin histochemistry and immunohistochemical assessment of carcinoembryonic antigen, keratin proteins, epithelial membrane antigen and milk fat globule derived antigen
42. Application of monoclonal antibody 44-3A6 in the cytodiagnosis and classification of pulmonary carcinomas
43. Use of monoclonal antibody (B72.3) as an immunocytochemical adjunct to diagnosis of adenocarcinoma in human effusions
44. Endocrine related biochemistry in the spectrum of human lung carcinoma
45. Peptide hormone production in primary lung tumors
46. A nonrandom chromosomal abnormality, del 3p(14–23) in human small cell lung cancer
47. Cytogenetics of small cell carcinoma of the lung
48. Molecular analysis of the short arm of chromosome 3 in small cell and non small cell carcinoma of the lung
49. Deletion 3p delineates two groups of human lung cancers expressing neuroendocrine cell markers
50. The neuroendocrine components of the bronchopulmonary tract: Hyperplasias, dysplasias and neoplasms
51. Specific endocrine tissue marker defined by a monoclonal antibody
52. Synaptophysin—a new and promising panneuroendocrine marker